Regeneron Pharmaceuticals Inc (REGN) TriNetX Collaborates with Regeneron to Access De-Identified Electronic Health Records of 300 Million Patients to Drive Research and Product Development in Life Sciences and Digital Health Solutions

Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release

Newsdesk: